Uncategorized
Ocular Therapeutix™ to Participate at the Cantor Fitzgerald Inaugural Healthcare Conference
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Brad Smith, Chief Financial Officer, will present a corporate overview at the Cantor Fitzgerald Inaugural Healthcare Conference on Wednesday, July 8, 2015 at 9:00 a.m. EDT at the Le Parker Meridien Hotel in New York City. Also at the conference, Scott Corning, Vic
